Literature DB >> 8447385

Increased proliferation of osteoblast precursor cells in estrogen-deficient rats.

D Modrowski1, L Miravet, M Feuga, P J Marie.   

Abstract

We have evaluated the in vivo and in vitro changes in osteoblast characteristics induced by estrogen deficiency and 17 beta-estradiol (E2) treatment in ovariectomized (OVX) rats. Estrogen deficiency induced osteopenia and increased bone turnover, as evidenced by bone histomorphometry at 1, 3, and 6 mo postovariectomy. Bone surface osteoblastic cells (OB) isolated from tibias of OVX rats, OVX rats treated with E2 (10 micrograms/kg body wt), and sham rats showed no difference in alkaline phosphatase activity and osteocalcin production in vitro. In contrast the proliferation rate of OB cells was higher in OVX rats compared with sham rats at all time points post-surgery, as shown by [3H]thymidine incorporation and cell number. The proliferation rate of alkaline phosphatase-positive marrow cells was also higher in OVX rats compared with sham rats. E2 treatment of OVX rats corrected histologic indexes of bone resorption and formation and normalized OB cell proliferation. induced by estrogen deficiency in OVX rats is related to an increased proliferation of osteoblast precursor cells present in the marrow stroma and along the endosteal bone surface.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8447385     DOI: 10.1152/ajpendo.1993.264.2.E190

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption.

Authors:  R L Jilka; K Takahashi; M Munshi; D C Williams; P K Roberson; S C Manolagas
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

2.  Systemic administration of transforming growth factor-beta 2 prevents the impaired bone formation and osteopenia induced by unloading in rats.

Authors:  M Machwate; E Zerath; X Holy; M Hott; D Godet; A Lomri; P J Marie
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 3.  Strontium ranelate: a novel mode of action optimizing bone formation and resorption.

Authors:  P J Marie
Journal:  Osteoporos Int       Date:  2005-01       Impact factor: 4.507

Review 4.  Sex steroids and stem cell function.

Authors:  Rinki Ray; Nathan M Novotny; Paul R Crisostomo; Tim Lahm; Aaron Abarbanell; Daniel R Meldrum
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

5.  Short-term effects of organic silicon on trabecular bone in mature ovariectomized rats.

Authors:  M Hott; C de Pollak; D Modrowski; P J Marie
Journal:  Calcif Tissue Int       Date:  1993-09       Impact factor: 4.333

6.  Effect of strontium-containing hydroxyapatite bone cement on bone remodeling following hip replacement.

Authors:  Guo X Ni; Jian H Lin; Peter K Y Chiu; Zhao Y Li; William W Lu
Journal:  J Mater Sci Mater Med       Date:  2010-01       Impact factor: 3.896

Review 7.  The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity.

Authors:  Dalia Ali; Michaela Tencerova; Florence Figeac; Moustapha Kassem; Abbas Jafari
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-15       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.